Panta rhei, also drug eluting stent technology.
Mauro ChiaritoRoxana MehranPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
The Resolute zotarolimus eluting stent (ZES) is a next-generation durable polymer, thin-struts drug eluting stent. Although several randomized and observational studies have proven its safety and efficacy, long-term follow-up data are still limited. This prospective, multicenter, single arm study, showed favorable 5-year outcomes in patients undergoing Resolute ZES implantation, with considerably low rate of repeated revascularization and stent thrombosis. Data on long-term performance of next-generation drug eluting stents are of paramount importance to adequately inform decision-making in contemporary clinical practice.
Keyphrases
- patients undergoing
- clinical practice
- electronic health record
- double blind
- big data
- open label
- pulmonary embolism
- type diabetes
- percutaneous coronary intervention
- randomized controlled trial
- clinical trial
- emergency department
- adipose tissue
- coronary artery bypass grafting
- insulin resistance
- deep learning
- skeletal muscle
- atrial fibrillation
- weight loss
- data analysis
- study protocol
- drug induced